MarketFriction

Amar Remedies Ltd

BSE 532664 · Personal Care
Market cap₹Cr.
Not trading

Price

Drag to pan, scroll or pinch to zoom. Ruler (or Shift + drag) measures a move.Dashed lines: 52 week high and low. Prices adjusted for splits and bonuses.

Financials

Standalone, Rs crore
Dec 2011Dec 2012Mar 2013Jun 2013
Sales16516313145
Expenses14014512253
Operating Profit24189-8
OPM %15%11%7%-18%
Other Income10-7-4
Interest9121415
Depreciation3552
Profit before tax142-16-29
Tax %12%17%0%0%
Net Profit121-16-29
EPS in Rs4.690.51-6.17-11.03
Jun 2006Jun 2007Jun 2008Jun 2009Jun 2010Jun 2011Jun 2012
Sales167202298369472578674
Expenses139176263322404496561
Operating Profit282635486882113
OPM %17%13%12%13%14%14%17%
Other Income000211-3
Interest34812212740
Depreciation1227101113
Profit before tax24212630384557
Tax %14%17%17%11%15%15%21%
Net Profit21172227323845
EPS in Rs8.016.518.3210.2012.3314.5417.29
Dividend Payout %0%0%0%10%8%7%0%
10 Years5 Years3 YearsTTM1 YearLast Year
Compounded Sales Growth%27%22%17%
Compounded Profit Growth%24%23%29%
Stock Price CAGR%%%%
Return on Equity%20%20%21%
Jun 2006Jun 2007Jun 2008Jun 2009Jun 2010Jun 2011Jun 2012Dec 2012
Equity Capital2626262626262626
Reserves6480102126155190235238
Borrowings29535688124249365365
Other Liabilities1124294857255635
Total Liabilities129184213288362490683664
Fixed Assets262984108115124165161
CWIP16520001100
Investments00001111
Other Assets87102129180246354518502
Total Assets129184213288362490683664
Jun 2006Jun 2007Jun 2008Jun 2009Jun 2010Jun 2011Jun 2012
Cash from Operating Activity-91523-12-0-21
Cash from Investing Activity-42-40-5-31-18-49-58
Cash from Financing Activity5124329335776
Net Cash Flow0-00138-3
Free Cash Flow-46-26-3-28-30-31-63
CFO/OP-20%58%17%14%-18%8%-9%
Jun 2006Jun 2007Jun 2008Jun 2009Jun 2010Jun 2011Jun 2012
Debtor Days868783818388100
Inventory Days10095103138111122167
Days Payable61171491011
Cash Conversion Cycle180171179205186199255
Working Capital Days157134119127141185230
ROCE %18%20%20%22%19%19%

Fundamentals

Market Cap₹ Cr.
Current Price₹ 6.07
Book Value₹ 99.8
ROCE18.7 %
ROE20.6 %
Dividend Yield0.00 %
Face Value₹ 10.0
Compounded Sales Growth (TTM)17%
Compounded Profit Growth (TTM)29%
Standalone figures.
Valuation
P/E, 3-year average3.64x
P/B, 3-year average0.61x
Profitability
Operating margin (excl. other income)12.87%
Operating margin (incl. other income)13.38%
EBITDA margin13.38%
Pre-tax margin8.09%
Net profit margin7.23%
ROE19.04%
ROCE19.91%
ROA10.65%
ROE, 3-year average18.31%
ROCE, 3-year average19.12%
ROA, 3-year average10.83%
ROIC (approx.)15.78%
Tax rate10.62%
Other income / net worth1.24%
Growth
Sales growth (latest year)23.79%
Profit growth (latest year)22.61%
Sales CAGR, 3 years30.23%
Profit CAGR, 3 years8.39%
Per share
EPS (TTM)Rs 10.20
EPS (latest year)Rs 10.20
EPS, 3-year averageRs 8.34
Book value per shareRs 58.05
Sales per shareRs 141.09
Cash flow per shareRs 1.12
Free cash flow per shareRs -24.08
Dividend per share (latest year)Rs 1.00
Dividend per share, 3-year averageRs 1.00
Dividends
Dividend payout9.82%
Dividend payout, 3-year average9.82%
Efficiency
Asset turnover1.28x
Fixed asset turnover3.41x
Inventory turnover3.78x
Inventory days96 days
Debtor days81 days
Debtors turnover4.48x
Creditor days11 days
Cash conversion cycle255 days
Working capital days230 days
Leverage
Total debtRs 88 Cr
Cash and bankRs 1 Cr
Net debtRs 88 Cr
Debt to equity0.58x
Net debt / EBITDA1.77x
Interest coverage3.40x
Owners' fund to total sources52.75%
Debt to assets30.66%
Cash flow
Cash from Operating Activity (latest year)Rs 3 Cr
Cash from Investing Activity (latest year)Rs -31 Cr
Cash from Financing Activity (latest year)Rs 29 Cr
Net Cash Flow (latest year)Rs 1 Cr
Free cash flow (latest year)Rs -63 Cr
FCFE (approx.: FCF + change in debt)Rs -31 Cr
Cash from ops / profit, 5 years-0.17x
Sales to cash flow125.56x
Statement figures
Net sales (TTM)Rs 369 Cr
Net sales (latest year)Rs 369 Cr
Operating profit excl. other income (latest year)Rs 48 Cr
Other income (TTM)Rs 2 Cr
EBITDA (TTM)Rs 49 Cr
PBDT (TTM)Rs 37 Cr
Profit before tax (TTM)Rs 30 Cr
Tax (latest year)Rs 3 Cr
Net profit (TTM)Rs 27 Cr
Net profit (latest year)Rs 27 Cr
Depreciation (TTM)Rs 7 Cr
Interest (TTM)Rs 12 Cr
Cost of goods sold (latest year)Rs 304 Cr
Total expenditure (latest year)Rs 322 Cr
Total income (latest year)Rs 371 Cr
Share capitalRs 26 Cr
ReservesRs 126 Cr
Shareholders' fundsRs 152 Cr
Total assetsRs 288 Cr
Net blockRs 108 Cr
InvestmentsRs 0 Cr
ReceivablesRs 82 Cr
InventoryRs 80 Cr
Other liabilitiesRs 48 Cr
Shares outstanding (crore)2.62
Computed by MarketFriction from the standalone statements. Returns use average balances.
Not enough history to build valuation bands (needs two years of profits and prices).
Not enough price history.

Red flags

F-score 4 of 8
explainWeak cash conversion Cash from operations was 31% of net profit over the last 3 years
lookInventory outrunning sales Inventory grew 64% vs sales +24% in 2012
Checks on the latest reported years: cash vs profit, accruals, receivables and inventory vs sales, dilution, debt, interest cover, equity, other income, losses, and auditor, top-management, insolvency and regulator filings in the last 12 months. A flag asks for an explanation; it is not a verdict.

Latest quarter

No quarterly results published.

Activity

Compare
CompanyMcap (Cr)P/EROCE
Godrej Consumer Products Ltd87,49342.118.8 %
Dabur India Ltd67,48134.020.3 %
Colgate-Palmolive (India) Ltd48,55235.5108 %
Cupid Ltd38,72628233.9 %
Gillette India Ltd22,69434.090.7 %
Procter & Gamble Hygiene and Health Care Ltd22,30528.2157 %
Emami Ltd16,63322.028.1 %
Honasa Consumer Ltd14,39957.019.2 %
Bajaj Consumer Care Ltd6,43928.930.0 %
Anondita Medicare Ltd2,08562.343.8 %
Recode Studios Ltd45440.574.1 %
Radix Industries (India) Ltd20369.219.6 %
Macobs Technologies Ltd18965.311.0 %
H. R. Hygiene Products Ltd15613.730.4 %
Thrive Future Habitats Limited100-7.67 %
No bulk or block deals on record.
No corporate actions on record.
No announcements in our files yet.
Company filings to NSE, newest first. Routine notices (trading window, newspaper copies) are left out. Click a row for the filing.
No short selling reported to NSE in our files.
Short sales disclosed by brokers to NSE, by trade date. Collected since late September 2026.
Not on any NSE surveillance list in the latest file.

Quick answers

What is the market cap of Amar Remedies Ltd?

Amar Remedies Ltd (532664) has a market capitalisation of Rs Cr. at the close.

Data: NSE and BSE daily reports, company filings. Numbers only, not investment advice, not a SEBI-registered research service.AboutMethodologyFAQResearchContactTermsPrivacyDisclaimerUpdated 2026-10-03